Expanding Business and Capital Alliance Contract with HEALIOS K.K. to develop practical applications for regenerative medicine

July 10, 2019 TOKYO – Nikon Corporation (Nikon) agreed on the expansion of partnership between HEALIOS K.K. (Hardy TS Kagimoto, CEO, Tokyo, Japan, hereafter referred to as Healios) based on the business and capital alliance agreement concluded in 2017. Based on this agreement, Nikon will accept 4 billion yen of series 2 unsecured convertible bonds... Read more

PerkinElmer Launches CE-Marked Infectious Disease Immunoassays on EUROIMMUN Random Access Instrument

ChLIA-based tests for detection of antibodies against Borrelia and Epstein-Barr Virus now available on EUROIMMUN RA Analyzer 10 System WALTHAM, Mass. – July 10, 2019 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the first two CE-marked chemiluminescence immunoassays (ChLIA) for the detection of anti-Borrelia (Lyme disease) and... Read more

Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies LLC

Acquisition strengthens Bruker’s portfolio of high-performance PET molecular imaging solutions ZURICH, Switzerland, July 8, 2019 /PRNewswire/ — Bruker today announced that it has acquired PMOD Technologies LLC, a highly respected provider of research-use-only software for preclinical and molecular imaging, with a focus on molecular quantification and pharmacokinetic modeling. The PMOD software is widely used for... Read more

Century Therapeutics Launches with $250M Financing for iPSC Allogeneic Cell Therapy Platform

Tokyo, June 1, 2019 ― FUJIFILM Corporation (President: Kenji Sukeno) will accelerate the development of next-generation cancer immunotherapeutic drug candidates by harnessing the self-renewal potential of allogenic induced pluripotent stem cells (iPSCs). FUJIFILM Cellular Dynamics, Inc. (FCDI), a leading developer and manufacturer of human iPSCs and tissue-specific cells differentiated from iPSCs, and Versant Venture Management,... Read more

Quanterix Announces Kevin Hrusovsky, Chairman and Chief Executive Officer, and Founder of Powering Precision Health, as EY Entrepreneur of the Year 2019 Award Winner in New England

JUNE 28, 2019 June 28, 2019 12:15 PM Eastern Daylight Time BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that Kevin Hrusovsky, Chairman and CEO of Quanterix, and Founder of Powering Precision Health (PPH), has been recognized with the Entrepreneur Of The... Read more

IDT signs strategic partnership with Chinese medical sequencing firm ChosenMed

Jun 27, 2019 Partnership strengthens IDT’s position as an NGS leader in China CORALVILLE, IA (June 27, 2019) – Integrated DNA Technologies (IDT) announces that is has entered into a strategic cooperation with ChosenMed Technology (Beijing) Co., Ltd (ChosenMed), a medical sequencing firm focused on personalized medicine and transformation healthcare in China. As part of the collaboration, IDT... Read more

United States and Indonesia Expand Collaboration to End Tuberculosis

Jun 27, 2019 JAKARTA (June 27, 2019) — Today, the United States Government through the United States Agency for International Development (USAID) and BD (Becton, Dickinson and Company), a U.S.-based global medical technology company, formalized a new partnership to support Indonesia in eliminating tuberculosis (TB) through its National Tuberculosis Program. “Fighting TB with our Indonesian partners... Read more

Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament Light (Nf-L) Antibody Supplier

JUNE 26, 2019 Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament Light (Nf-L) Antibody Supplier Positions Quanterix to capitalize on significant growth opportunities with Nf-L applications in Alzheimer’s Disease, Multiple Sclerosis, and other neurodegenerative conditions Provides expected 200 bps of annualized company gross margin improvement, before impact of purchase price accounting, and expected to... Read more

Steven Daniel joins Cofactor Genomics as Vice President of Business Development

— Leading Cofactor’s commercial efforts to grow the Predictive Immune Modeling market   — San Francisco, June 20, 2019 (REPORTABLE) — Cofactor Genomics today announced the appointment of Steven Daniel, PhD as Vice President of Business Development, overseeing the development and execution of the company’s sales strategy and sales management. Dr. Daniel comes to Cofactor from... Read more

QIAGEN Clinical Insight surpasses 1 million patient test cases analyzed and interpreted

Hilden, Germany, and Germantown, Maryland, June 20, 2019 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that QIAGEN Clinical Insight (QCI®), its clinical decision support platform for interpretation and reporting of variants derived from analysis of next-generation sequencing (NGS) data, has achieved a milestone of more than 1 million patient test cases analyzed... Read more